WHERE ARE WE NOW WITH CIPROFLOXACIN

被引：7

作者：

HAWKEY, PM

机构：

来源：

关键词：

D O I：

10.1093/jac/24.4.477

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：477 / 480

页数：4

共 28 条

[1] ARYA OP, 1986, GENITOURIN MED, V62, P170
[2] CIPROFLOXACIN - AN OVERVIEW OF ADVERSE EXPERIENCES
BALL, P
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 187 - 193
[3] de Witte T, 1987, Pharm Weekbl Sci, V9 Suppl, pS48
[4] EYKYN SJ, 1987, LANCET, V2, P1407
[5] FLEMING LW, 1988, 2ND INT S NEW QUIN G, P261
[6] GILBERT DN, 1987, AM J MED, V82, P254
[7] EFFICACY AND SAFETY OF CIPROFLOXACIN IN PATIENTS WITH RESPIRATORY-INFECTIONS IN COMPARISON WITH AMOXICILLIN
GLEADHILL, IC
FERGUSON, WP
LOWRY, RC
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 133 - 138
[8] GOLDSTEIN EJC, 1987, AM J MED, V82, P284
[9] HODSON ME, 1987, LANCET, V1, P235
[10] TREATMENT OF CHRONIC OSTEOMYELITIS WITH CIPROFLOXACIN
HOOGKAMPKORSTANJE, JAA
VANBOTTENBURG, HA
VANBRUGGEN, J
DAVIDSON, JSA
DETMAR, SJ
DEGRAAF, W
RIJNKS, J
YPMA, JFAM
DEZWART, DF
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (03) : 427 - 432